ISSN: 0213-005X

Indexed in:

Index Current Contents/Clinical Medicine, JCR, SCI-Expanded, Index Medicus/Medline, Excerpta Medica/EMBASE, IBECS, IME, CANCERLIT, SCOPUS

Subscribe:

Impact factor

The Impact Factor measures the average number of citations received in a particular year by papers published in the journal during the two preceding years.

© Clarivate Analytics, Journal Citation Reports 2022

Impact factor 2023

2.6

Citescore

CiteScore measures average citations received per document published.

Citescore 2023

2.1

SJR

SRJ is a prestige metric based on the idea that not all citations are the same. SJR uses a similar algorithm as the Google page rank; it provides a quantitative and qualitative measure of the journal's impact.

SJR 2023

0.355

SNIP

SNIP measures contextual citation impact by wighting citations based on the total number of citations in a subject field.

SNIP 2023

0.381

View more metrics

Journal Information

Back to article

Statistics

Follow this link to access the full text of the article

Scientific letter

First isolation in Spain of Paracoccus sanguinis in blood cultures

Primer aislamiento en España de Paracocus sanguinis en hemocultivos

Fernando Coboa,

Corresponding author

fernando.cobo.sspa@juntadeandalucia.es

Corresponding author.

, Mª José Medinab, José María Navarro-María, Sylvia Valdezateb

a Department of Microbiology and Instituto de Investigación Biosanitaria ibs.GRANADA, University Hospital Virgen de las Nieves, Granada, Spain

b Reference and Research Laboratory for Taxonomy, National Center of Microbiology ISCIII, Madrid, Spain

Read

2558

Times
was read the article

659

Total PDF

1899

Total HTML

Share statistics

Article information

ISSN: 0213005X
Original language: English

DOI:10.1016/j.eimc.2020.09.011

The statistics are updated each day

Year/Month	Html	Pdf	Total

2024 August	17	3	20
2024 July	44	9	53
2024 June	42	15	57
2024 May	29	15	44
2024 April	51	76	127
2024 March	72	31	103
2024 February	79	15	94
2024 January	63	35	98
2023 December	65	36	101
2023 November	74	33	107
2023 October	77	48	125
2023 September	53	20	73
2023 August	45	3	48
2023 July	65	15	80
2023 June	53	7	60
2023 May	69	12	81
2023 April	101	5	106
2023 March	66	19	85
2023 February	44	17	61
2023 January	50	6	56
2022 December	45	16	61
2022 November	50	23	73
2022 October	47	20	67
2022 September	43	22	65
2022 August	46	20	66
2022 July	36	12	48
2022 June	36	20	56
2022 May	41	20	61
2022 April	66	33	99
2022 March	58	11	69
2022 February	56	6	62
2022 January	5	4	9
2021 December	95	4	99
2021 October	12	3	15
2021 September	28	8	36
2021 August	76	15	91
2020 November	0	2	2

Show all

Follow this link to access the full text of the article

Publish in

Enfermedades Infecciosas y Microbiología Clínica

Free access articles

Uncommon lip lesions in an HIV...

10.1016/j.eimc.2024.06.017

Tolerance of Atovacuona/proguanil in off-label...

10.1016/j.eimc.2024.06.012

Resumen ejecutivo de las Guías Española de...

Enferm Infecc Microbiol Clin. 2024;42:380-5

La Sociedad Española de Enfermedades Infecciosas y Microbiología Clínica agradece la colaboración de:

SOCIOS PROTECTORES

SOCIOS PATROCINADORES

- Becton Dickinson S.A.U.
- Janssen-Cilag, S.A.
- Angelini Farmacéutica, S.A.
- Biomerieux España, S,A.U.
- Merck Sharp & Dohme de España, S.A.
- Hologic Iberia, S.L.U.
- Laboratorios Menarini S.A.
- Accelerate Diagnostics S.L.
- Abbott Laboratories, S.A.
- Cepheid Iberia S.L.U.
- Illumina Productos de España. S.L.U.
- DiaSorin Iberia, S.A.
- GlaxoSmithKline, S.A.
- Sysmex España S.L.

Enfermedades Infecciosas y Microbiología Clínica follows the Recommendations for the Conduct, Reporting, Editing and Publication of Scholarly Work in Medical Journals

Indexed in:

Follow us:

Subscribe:

Statistics

Subscribe to our newsletter